Significant Ownership of David D. Chang

Location
South San Francisco, CA
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by David D. Chang.

Notify me when David D. Chang files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of David D. Chang

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ALLO Allogene Therapeutics, Inc. Common Stock 4.9% $13.9M $122K 11.2M +0.88% David D. Chang, M.D., Ph.D. Sep 30, 2025

Schedules 13D/G Reported by David D. Chang:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.